How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.
Debbie Berkowitz joins Ethics Talk to discuss her article, coauthored with Anna D. Goff, Dr Kathleen Marie Fagan, and Dr Monica L. Gerrek: "Do Clinics in Meat and Poultry Plants Endanger Workers?”
Dr Anne Graff LaDisa joins Ethics Talk to discuss her article, coauthored with Drs Erica Chou, Amy Zelenski, and Sara Lauck: “How to Use Improv to Help Interprofessional Students Respond to Status and Hierarchy in Clinical Practice.”
Dr Lisa Lehmann joins Ethics Talk to discuss “grateful patient programs,” pressures clinicians face to fundraise on behalf of health care organizations for which they work, and whether “VIP” care really is better for patients.
Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”
Michaela Chan joins Ethics Talk to discuss her own comic-making practice, the challenges of representing ethical concepts visually, and how comics disrupt expectations in academic settings.
Dr Ala Shaikhkhalil joins Ethics Talk to discuss her article, coauthored with Drs Ethan A. Mezoff and Hannah Hays: “Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D?”
Dr Ghassan S. Abu-Sittah joins Ethics Talk to discuss his article, coauthored with Dr Thalia Arawi and Bashar Hassan: “Everyone Is Harmed When Clinicians Aren’t Prepared”
